The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading

Beck, Roy W., Connor, Crystal G., Mullen, Deborah M., Wesley, David M., Bergenstal, Richard M.·2017·Diabetes Care
DOI 10.2337/dc17-0636

Cited by (478)

Items 101–200 of 478

  1. Development of Diabetes after Pancreaticoduodenectomy: Results of a 10-Year Series Using Prospective Endocrine Evaluation
    Daniel W. Maxwell, Mohammad Raheel Jajja, Marvi Tariq, Zayan Mahmooth, Rodolfo Javier Galindo, John F. Sweeney, Juan Manuel Sarmiento · 2019 · Journal of the American College of Surgeons
  2. HbA1c
    Anders L. Carlson, Amy B. Criego, Thomas W. Martens, Richard M. Bergenstal · 2019 · Endocrinology and Metabolism Clinics of North America
  3. A Kinetic Model for Glucose Levels and Hemoglobin A1c Provides a Novel Tool for Individualized Diabetes Management
    Yongjin Xu, Timothy C. Dunn, Ramzi Ajjan · 2020 · Journal of Diabetes Science and Technology
  4. Clinical Application of Time in Range and Other Metrics
    Grazia Aleppo · 2021 · Diabetes Spectrum
  5. Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes
    Zhu, Jia, Volkening, Lisa K., Laffel, Lori M. · 2020 · Diabetes Care
  6. Reframing prediabetes: A call for better risk stratification and intervention
    Sun H. Kim · 2024 · Journal of Internal Medicine
  7. Choice of Continuous Glucose Monitoring Systems May Affect Metrics: Clinically Relevant Differences in Times in Ranges
    Guido Freckmann, Stefan Pleus, Sebastian Schauer, Manuela Link, Nina R. M. Jendrike, Delia Waldenmaier, Cornelia Haug, Andreas Stuhr · 2021 · Experimental and Clinical Endocrinology & Diabetes
  8. Consensus report: Definition and interpretation of remission in type 2 diabetes
    Matthew C. Riddle, William T. Cefalu, Philip Hugh Evans, Hertzel C. Gerstein, Michael Albrecht Nauck, William K. Oh, Amy E. Rothberg, Carel Wynand le Roux, Francesco Rubino, Philip R. Schauer et al. · 2021 · Diabetic Medicine
  9. Protein glycation in diabetes mellitus
    Aleks Shin, Shawn M. Connolly, Kuanysh Kabytaev · 2023 · Advances in clinical chemistry
  10. Diabetic peripheral neuropathy and glycemic variability assessed by continuous glucose monitoring: A systematic review and meta-analysis
    Yifan Jia, Dan Long, Yunshuang Yang, Qiong Wang, Qunli Wu, Qian Zhang · 2024 · Diabetes Research and Clinical Practice
  11. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol
    Sybil A. McAuley, Martin I. de Bock, Vijaya Sundararajan, Melissa H. Lee, Barbora Paldus, Geoffrey R. Ambler, Leon A. Bach, Morton G. Burt, Fergus J. Cameron, Philip Clarke et al. · 2018 · BMJ Open
  12. Post-Pancreatectomy Diabetes Index: A Validated Score Predicting Diabetes Development after Major Pancreatectomy
    Daniel W. Maxwell, Mohammad Raheel Jajja, Rodolfo Javier Galindo, Chao Zhang, Syed Omair Nadeem, John F. Sweeney, Catherine M. Blair, Juan Manuel Sarmiento · 2020 · Journal of the American College of Surgeons
  13. Software Packages and Tools for the Analysis of Continuous Glucose Monitoring Data
    Agnese Piersanti, Francesco Giurato, Christian S. Göbl, Laura Burattini, Andrea Tura, Micaela Morettini · 2022 · Diabetes Technology & Therapeutics
  14. Continuous glucose monitoring among adults with type 2 diabetes receiving noninsulin or basal insulin therapy in primary care
    Shields, Stephen, Thomas, Roy, Durham, Joy, Moran, Joseph, Clary, Jake, Ciemins, Elizabeth L. · 2024 · Scientific Reports
  15. The Role of Continuous Glucose Monitoring, Diabetes Smartphone Applications, and Self-Care Behavior in Glycemic Control: Results of a Multi-National Online Survey
    Mihiretu M. Kebede, Cora Schuett, Claudia Ruth Pischke · 2019 · Journal of Clinical Medicine
  16. The Role of Protein and Fat Intake on Insulin Therapy in Glycaemic Control of Paediatric Type 1 Diabetes: A Systematic Review and Research Gaps
    Dieter Furthner, Andreas Lukas, Anna-Maria Schneider, Katharina Mörwald, Katharina Maruszczak, Petra Gombos, Julian Gomahr, Claudia Steigleder‐Schweiger, Daniel Weghuber, Thomas Pixner · 2021 · Nutrients
  17. Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?
    Christopher Martin, Amy B. Criego, Anders L. Carlson, Richard M. Bergenstal · 2019 · Current Diabetes Reports
  18. Stepwise approach to continuous glucose monitoring interpretation for internists and family physicians
    Szmuilowicz, Emily D., Aleppo, Grazia · 2022 · Postgraduate Medicine
  19. Type 2 diabetes mellitus management in patients with chronic kidney disease: an update
    Zoi Kleinaki, Stella Kapnisi, Sofia‐Andriani Theodorelou‐Charitou, Ilias P. Nikas, Stavroula Α. Paschou · 2020 · HORMONES
  20. Estimating Glycemia From HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy
    Veronica Tozzo, Matthew T. Genco, Shammah O. Omololu, Christopher Mow, Hasmukh R. Patel, Chhaya H. Patel, Samantha N. Ho, Evie Lam, Batoul Abdulsater, Nikita Patel et al. · 2024 · Diabetes Care
  21. Beyond HbA<sub>1c</sub>: using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision‐making
    Brown, S. A., Basu, A., Kovatchev, B. P. · 2019 · Diabetic Medicine
  22. Continuous Glucose Monitoring Profiles in Healthy, Nondiabetic Young Children
    Stephanie N. DuBose, Lauren G. Kanapka, Brenda Bradfield, Morgan Sooy, Roy W. Beck, Andrea K. Steck · 2022 · Journal of the Endocrine Society
  23. Diabetic neuropathy: Past, present, and future.
    Juan Eduardo Quiroz Aldave, María del Carmen Durand‐Vásquez, Elman Rolando Gamarra Osorio, Jacsel Suárez-Rojas, Pela Jantine Roseboom, Rosa María Alcalá‐Mendoza, Julia Arroyo, Francisca Elena Zavaleta‐Gutiérrez, Luis Alberto Concepción Urteaga, Marcio José Concepción‐Zavaleta · 2023 · PubMed Central
  24. Racial differences in performance of HbA1c for the classification of diabetes and prediabetes among US adults of non‐Hispanic black and white race
    Christopher Nicholaus Ford, R Whitney Leet, Lauren M. Kipling, Mary K. Rhee, Sandra L. Jackson, Peter W.F. Wilson, Lawrence S. Phillips, Lisa R. Staimez · 2019 · Diabetic Medicine
  25. TXNIP DNA methylation is associated with glycemic control over 28 years in type 1 diabetes: findings from the Pittsburgh Epidemiology of Diabetes Complications (EDC) study
    Rachel G. Miller, Josyf C. Mychaleckyj, Suna Önengüt-Gümüşcü, Trevor John Orchard, Tina Costacou · 2023 · BMJ Open Diabetes Research & Care
  26. Continuous glucose monitoring assessment of metabolic control in east African children and young adults with type 1 diabetes: A pilot and feasibility study
    Lauren McClure Yauch, Eric P. Velazquez, Thereza Piloya, Lucy Mungai, Anjumanara Anver Omar, Antoinette Moran · 2020 · Endocrinology Diabetes & Metabolism
  27. Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring
    Caroline Trunk‐Black Juel, Thomas Fremming Dejgaard, Carsten Palnæs Hansen, Jan Henrik Storkholm, Tina Vilsbøll, Asger Lund, Filip Krag Knop · 2020 · The Journal of Clinical Endocrinology & Metabolism
  28. Novel Continuous Glucose Monitoring Metrics and Large-for-Gestational-Age Risk: An Exploratory Retrospective Cohort Study in Pregnancies with Type 1 Diabetes
    Rafał Sibiak, Paweł Gutaj, Beata Mrzewka-Rogacz, Urszula Mantaj, Ewa Wender-Ożegowska · 2021 · Diabetes Technology & Therapeutics
  29. Associations of Time in Range and Other Continuous Glucose Monitoring–Derived Metrics With Well-Being and Patient-Reported Outcomes: Overview and Trends
    Dominic Ehrmann, Lilli Priesterroth, ANDREAS J. SCHMITT, Bernhard Kulzer, Norbert Hermanns · 2021 · Diabetes Spectrum
  30. Time in range—A new gold standard in type 2 diabetes research?
    Ashni Goshrani, Rose Lin, David Norman O'Neal, Elif Ilhan Ekinci · 2025 · Diabetes Obesity and Metabolism
  31. Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus
    Masayuki Ikeda, Rumiko Shimazawa · 2019 · Journal of General and Family Medicine
  32. Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes
    Friedman, Jared G, Coyne, Kasey, Aleppo, Grazia, Szmuilowicz, Emily D · 2023 · Endocrine Connections
  33. Innovative solution or cause for concern? The use of continuous glucose monitors in people not living with diabetes: A narrative review
    Zhanna Oganesova, John H. Pembérton, Adrian Carl Brown · 2024 · Diabetic Medicine
  34. Access to insulin delivery devices and glycated haemoglobin in lower-income countries
    Emma Louise Klatman, Graham David Ogle · 2020 · World Journal of Diabetes
  35. The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review
    Evanthia Gouveri, Νικόλαος Παπάνας · 2022 · Diabetes Therapy
  36. Thrice daily consumption of a novel, premeal shot containing a low dose of whey protein increases time in euglycemia during 7 days of free-living in individuals with type 2 diabetes
    Kieran Smith, Guy Taylor, Lise H Brunsgaard, Mark Walker, Kelly A. Bowden Davies, Emma Stevenson, Daniel J. West · 2022 · BMJ Open Diabetes Research & Care
  37. Utility of time in tight range (TITR) in evaluating metabolic control in pediatric and adult patients with type 1 diabetes in treatment with advanced hybrid closed-loop systems
    Pilar Bahillo-Curieses, Pablo Fernández-Velasco, Paloma Pérez-López, Ana María Vidueira Martínez, María de la O Nieto de la Marca, Gonzalo Díaz-Soto · 2024 · Endocrine
  38. Impacts of glycemic variability on the relationship between glucose management indicator from iPro ™ 2 and laboratory hemoglobin A1c in adult patients with type 1 diabetes mellitus
    Hongxia Liu, Daizhi Yang, Hongrong Deng, Wen Xu, Jing Lv, Yongwen Zhou, Sihui Luo, Xueying Zheng, Hua Liang, Bin Yao et al. · 2020 · Therapeutic Advances in Endocrinology and Metabolism
  39. The Clinical Application of Mealtime Whey Protein for the Treatment of Postprandial Hyperglycaemia for People With Type 2 Diabetes: A Long Whey to Go
    Kieran Smith, Kelly A. Bowden Davies, Emma Stevenson, Daniel J. West · 2020 · Frontiers in Nutrition
  40. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes
    Claudia Anita Piona, Marco Marigliano, Enza Mozzillo, Francesco Maria Rosanio, Angela Zanfardino, Dario Iafusco, Giulio Maltoni, Stefano Zucchini, Elvira Piccinno, Maurizio Delvecchio et al. · 2021 · Diabetes Research and Clinical Practice
  41. Beyond A1C—Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve
    Roy W. Beck, Richard M. Bergenstal · 2021 · Diabetes Spectrum
  42. Metabolic control during the SARS‐CoV ‐2 lockdown in a large German cohort of pediatric patients with type 1 diabetes: Results from the DPV initiative
    Johanna E Hammersen, Felix Reschke, Sascha René Tittel, Angeliki Pappa, Axel Dost, Katharina Köstner, Joachim Rosenbauer, Thomas Michael Kapellen, Tilman Robert Rohrer, Reinhard Walter Holl · 2022 · Pediatric Diabetes
  43. The best insulin delivery is a human pancreas
    Kasi R. McCune, Nina L. Owen‐Simon, Geoffrey K. Dube, Lloyd E. Ratner · 2023 · Clinical Transplantation
  44. Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
    Viswanathan Mohan, Shashank Joshi, Ambrish Mithal, Jothydev Kesavadev, AG Unnikrishnan, Banshi Saboo, Prasanna R. G. Kumar, Manoj S Chawla, Abhijit Bhograj, RAJIV R. KOVIL · 2023 · Diabetes Therapy
  45. A two-sample Mendelian randomization study explores metabolic profiling of different glycemic traits
    Tommy Hon Ting Wong, Jacky Man Yuen Mo, Mingqi Zhou, Jie V. Zhao, Catherine Mary Schooling, Baoting He, Shan Luo, Shiu Lun Au Yeung · 2024 · Communications Biology
  46. Managing discordance between HbA 1c and glucose management indicator
    Erna Lenters‐Westra, Marion J. Fokkert, Eric S Kilpatrick, Erwin D. Schleicher, Scott J. Pilla, Emma English, Peter Ruben van Dijk · 2025 · Diabetic Medicine
  47. Time in Range as a Research Outcome Measure
    Joseph Gerard Timmons, James G. Boyle, John R. Petrie · 2021 · Diabetes Spectrum
  48. Association of time in range with postoperative wound healing in patients with diabetic foot ulcers
    Ze‐Xin Huang, Hui‐Hui Zhang, Ying Huang, Sheng-lie Ye, Yu‐Ning Ma, Ying‐Huan Xin, Xiao‐Qian Chen, Sheng Zhao · 2021 · International Wound Journal
  49. Racial and Ethnic Differences in the Association Between Mean Glucose and Hemoglobin A1c
    Andrew John Karter, Melissa M. Parker, Howard H. Moffet, Lisa K. Gilliam · 2023 · Diabetes Technology & Therapeutics
  50. Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c
    Anna R. Kahkoska, Linda S. Adair, Allison E. Aiello, Kyle Stanley Burger, John B. Buse, Jamie Crandell, David M. Maahs, Crystal T. Nguyen, Michael R. Kosorok, Elizabeth J. Mayer‐Davis · 2019 · Pediatric Diabetes
  51. Rethinking Carbohydrate Intake and Time in Range in Children and Adolescents with Type 1 Diabetes
    Valentino Cherubini, Monica Marino, Marco Marigliano, Claudio Maffeis, Angela Zanfardino, Ivana Rabbone, Sara Giorda, Riccardo Schiaffini, Antonella Lorubbio, Assunta Serena Rollato et al. · 2021 · Nutrients
  52. Advancing blood glucose prediction with neural architecture search and deep reinforcement learning for type 1 diabetics
    Peter Domanski, Aritra Ray, Kyle Jon Lafata, Farshad Firouzi, Krishnendu Chakrabarty, Dirk Pflüger · 2024 · Journal of Applied Biomedicine
  53. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion
    Guy Massa, Inge Gys, Esmiralda Bevilacqua, Anne Wijnands, Renate Zeevaert · 2019 · Diabetes Research and Clinical Practice
  54. The relationship between glycosylated hemoglobin, time-in-range and glycemic variability in type 1 diabetes patients under flash glucose monitoring
    Gonzalo Díaz-Soto, Pilar Bahillo-Curieses, Rebeca Jimenez, María de la O Nieto de la Marca, Emilia Gomez, Beatriz Torres, Juan José López Gómez, Daniel Antonio de Luis · 2021 · Endocrinología Diabetes y Nutrición (English ed )
  55. Potential misclassification of diabetes and prediabetes in the U.S.: Mismatched HbA1c and glucose in NHANES 2005–2016
    Lisa R. Staimez, Lauren M. Kipling, J. Nina Ham, Brian T. Legvold, Sandra L. Jackson, Peter W.F. Wilson, Mary K. Rhee, Lawrence S. Phillips · 2022 · Diabetes Research and Clinical Practice
  56. Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials
    Sofia Sterner Isaksson, Henrik Imberg, Irl B. Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström et al. · 2024 · Diabetologia
  57. Influence of Medical and Geriatric Factors on Implant Success: An Overview of Systematic Reviews
    Tobias Fretwurst, Katja Nelson · 2021 · The International Journal of Prosthodontics
  58. Hemoglobin A1c Patterns of Youth With Type 1 Diabetes 10 Years Post Diagnosis From 3 Continents
    Jennifer L. Sherr, Anke Schwandt, Helen Phelan, Mark Allen Clements, Reinhard Walter Holl, Paul Benitez‐Aguirre, Kellee M. Miller, Joachim Woelfle, Thomas Dover, David M. Maahs et al. · 2021 · PEDIATRICS
  59. Assessment of Hyperglycemia, Hypoglycemia and Inter-Day Glucose Variability Using Continuous Glucose Monitoring among Diabetic Patients on Chronic Hemodialysis
    Maria Divani, Panagiotis I. Georgianos, Triantafyllos Didangelos, Vassilios Liakopoulos, Kali Makedou, Fotios S Iliadis, Christos G. Savopoulos, Dimitrios M. Grekas · 2021 · Journal of Clinical Medicine
  60. Type 1 Diabetes in Pregnancy: A Review of Complications and Management
    Mohammed S.B. Huda, Farah Jaffar, Kate Laycock · 2021 · Current Diabetes Reviews
  61. Pathophysiology, Diagnostic Criteria, and Approaches to Type 2 Diabetes Remission
    Abeer M Khamis · 2023 · Cureus
  62. Scans per day as predictors of optimal glycemic control in people with type 1 diabetes mellitus using flash glucose monitoring: what number of scans per day should raise a red flag?
    Fernando Sebastián‐Valles, Julia Martínez Alfonso, José Alfonso Arranz Martín, Jessica Jiménez‐Díaz, Iñigo Hernando Alday, Víctor Navas-Moreno, Teresa Armenta Joya, Maria del Mar Fandiño García, Gisela Liz Román Gómez, Luis Eduardo Lander Lobariñas et al. · 2023 · Acta Diabetologica
  63. The Calculation of the Glucose Management Indicator Is Influenced by the Continuous Glucose Monitoring System and Patient Race
    Edith Angellotti, Sangeetha Muppavarapu, Richard D. Siegel, Anastassios G. Pittas · 2019 · Diabetes Technology & Therapeutics
  64. Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels
    Richard M. Bergenstal, Robin L. Gal, Roy W. Beck · 2018 · Annals of Internal Medicine
  65. Insulin secretion and action affect glucose variability in the early stages of glucose intolerance
    Rumyana B. Dimova, Nevena Y. Chakarova, Giuseppe Daniele, Cristina Bianchi, Angela Dardano, Stefano Del Prato, Tsvetalina I. Tankova · 2022 · Diabetes/Metabolism Research and Reviews
  66. The association between dispositional mindfulness and glycemic control in type 1 diabetes during early adulthood: Differences by age and adverse childhood experiences
    Kathryn E. Nagel, Tracy Dearth‐Wesley, Allison N. Herman, Hannah G. Smith, Rachelle Gandica, Lauren Golden, Henry Weil, Robert C. Whitaker · 2020 · Pediatric Diabetes
  67. Assessment of metabolic control and use of flash glucose monitoring systems in a cohort of pediatric, adolescents, and adults patients with Type 1 diabetes
    Pilar Bahillo-Curieses, Gonzalo Díaz-Soto, Ana María Vidueira Martínez, Irune Torres Ballester, Emilia Gómez Hoyos, Daniel Antonio de Luis Román · 2021 · Endocrine
  68. HbA1c and Glucose Management Indicator Discordance Associated with Obesity and Type 2 Diabetes in Intermittent Scanning Glucose Monitoring System
    Fellinger, Paul, Rodewald, Karin, Ferch, Moritz, Itariu, Bianca, Kautzky-Willer, Alexandra, Winhofer, Yvonne · 2022 · Biosensors
  69. The influence of shorter red blood cell lifespan on the rate of HbA1c target achieved in type 2 diabetes patients with a HbA1c detection value lower than 7%
    Junmei Wang, Li Zhang, Yu Bai, Xinli Wang, Weilin Wang, Jing Li, Saijun Zhou · 2022 · Journal of Diabetes
  70. A Review of Continuous Glucose Monitoring Data Interpretation in the Age of Automated Insulin Delivery
    Laya Ekhlaspour, Ideen Tabatabai, Bruce A. Buckingham · 2019 · Journal of Diabetes Science and Technology
  71. Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes
    Zhouqin Feng, Qingyu Guo, Wei Wang, Yanyu Yuan, Xuguang Jin, Hui Zhou, Jun Liu, Haiyan Lei, Xinyi Yang, Jun Liu et al. · 2021 · Diabetology & Metabolic Syndrome
  72. Analyzing outcomes following pancreas transplantation: Definition of a failure or failure of a definition
    Robert J. Stratta, Alan C. Farney, Jonathan A. Fridell · 2022 · American Journal of Transplantation
  73. Glucodensity functional profiles outperform traditional continuous glucose monitoring metrics
    Marcos Matabuena, Rahul Ghosal, Javier Enrique Aguilar, Ayya Keshet, Robert J. Wagner, Carmen Fernández‐Merino, Juan Sánchez Castro, Vadim Zipunnikov, Jukka-Pekka “JP” Onnela, Francisco Gudé · 2025 · Scientific Reports
  74. Association of continuous glucose monitoring-derived time in range with major amputation risk in diabetic foot osteomyelitis patients undergoing amputation
    Xueyao Yin, Weifen Zhu, Chao Liu, Huilan Yao, Jiaxing You, Yixin Chen, Xiaofang Ying, Lin Li · 2022 · Therapeutic Advances in Endocrinology and Metabolism
  75. The ambulatory glucose profile and its interpretation
    Rose Lin, Fran Brown, Elif Ilhan Ekinci · 2022 · The Medical Journal of Australia
  76. Time in range, assessed with continuous glucose monitoring, is associated with brachial-ankle pulse wave velocity in type 2 diabetes: A retrospective single-center analysis
    Hui Zhou, Wei Wang, Qiuyue Shen, Zhouqin Feng, Zhen Zhang, Haiyan Lei, Xinyi Yang, Jun Liu, Bin Lü, Jiaqing Shao et al. · 2022 · Frontiers in Endocrinology
  77. Validation and verification framework and data integration of biosensors and in vitro diagnostic devices: a position statement of the IFCC Committee on Mobile Health and Bioengineering in Laboratory Medicine (C-MBHLM) and the IFCC Scientific Division
    Damien Gruson, Christa M. Cobbaert, Pradeep Kumar Dabla, Sanja Dj Stankovic, Evgenija Homšak, Kazuhiko Kotani, Ramy Samir Assaad, James H. Nichols, Bernard Gouget · 2024 · Clinical Chemistry and Laboratory Medicine (CCLM)
  78. Associations of continuous glucose monitor derived time in range and glycaemic variability with diet lifestyle and demographics
    Kate M. Bermingham, Harry Smith, Emma L. Duncan, Javier Thomas Gonzalez, Ana Maria Valdes, Paul W. Franks, Linda M. Delahanty, Hassan S. Dashti, Richard Davies, George M. Hadjigeorgiou et al. · 2026 · Nature Communications
  79. Using Flash Continuous Glucose Monitoring in Primary Practice
    Irl B. Hirsch, Eugene E. Wright · 2018 · Clinical Diabetes
  80. Exploratory Analysis of Glycemic Control and Variability Over Gestation Among Pregnant Women with Type 1 Diabetes
    Elizabeth Buschur, Kristen R. Campbell, Laura L. Pyle, Rachel Garcetti, Prakriti Joshee, Jamie K. Demmitt, Janet K. Snell‐Bergeon, Sarit Polsky · 2021 · Diabetes Technology & Therapeutics
  81. Associations between acute glucose control and peripheral nerve structure and function in type 1 diabetes
    Tushar Issar, Shyam Sunder Tummanapalli, Natalie C. G. Kwai, Jeremy Chung Bo Chiang, Ria Arnold, Ann M. Poynten, Maria Panayiota Markoulli, Arun V. Krishnan · 2020 · Diabetic Medicine
  82. Glycemic Control as an Early Prognostic Marker in Advanced Pancreatic Cancer
    Ipek Alpertunga, Rabail Sadiq, Deep S. Pandya, Tammy Lo, Maxim Dulgher, Sarah Evans, Bridget Bennett, Nancy J. Rennert, Richard C. Frank · 2021 · Frontiers in Oncology
  83. The oxytocin signalling gene pathway contributes to the association between loneliness and cardiometabolic health
    Adriano Winterton, Francesco Bettella, Dani Beck, Tiril Pedersen Gurholt, Nils Eiel Steen, Linn Nilsen Rødevand, Lars Tjelta Westlye, Ole A. Andreassen, Daniel S. Quintana · 2022 · Psychoneuroendocrinology
  84. Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19
    Tara Kaushal, LIANE J. TINSLEY, Lisa K. Volkening, Christine Turcotte, Lori M. Laffel · 2022 · The Journal of Clinical Endocrinology & Metabolism
  85. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis
    Keyu Guo, Jiaqi Li, Zhang Liyin, Jianan Ye, Li Fan, Zhiyi Ding, Zhou Qin, Xia Li, Yang Lin, Zhiguang Zhou · 2022 · Frontiers in Public Health
  86. Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes
    Xuguang Jin, Xinyi Yang, Yixin Xu, Jingjing Liang, Chunyan Liu, Qingyu Guo, Wei Wang, Zhouqin Feng, Yanyu Yuan, Hui Zhou et al. · 2023 · Diabetology & Metabolic Syndrome
  87. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels
    SURESH RAMA CHANDRAN, Robert Alan Vigersky, Andreas Thomas, Lee‐Ling Lim, Jeyakantha Ratnasingam, Alexander Tong Boon Tan, Daphne Su-Lyn Gardner · 2019 · Diabetes Technology & Therapeutics
  88. Continuous glucose monitoring in an end‐stage renal disease patient with diabetes receiving hemodialysis
    Yoko Narasaki, Elisa Park, Amy Seungsook You, Andrea C. Daza, Rene Amel Peralta, Yalitzi Guerrero, Alejandra Novoa, Alpesh Amin, Danh V. Nguyen, David A. Price et al. · 2021 · Seminars in Dialysis
  89. Advanced glycation end products via skin autofluorescence as potential marker of carotid atherosclerosis in patients with type 2 diabetes
    Lingwen Ying, Yun Shen, Yang Zhang, Yikun Wang, Yong Liu, Jun Yin, Yufei Wang, Jingrong Yin, Wei Zhu, Yuqian Bao et al. · 2021 · Nutrition Metabolism and Cardiovascular Diseases
  90. Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes
    Elena Toschi, Amy Lynn Michals, Atif Adam, DAI’QUANN J. DAVIS, Astrid Atakov-Castillo, Christine Slyne, Medha N. Munshi · 2021 · Diabetes Care
  91. Impact of blinded retrospective continuous glucose monitoring on clinical decision making and glycemic control in persons with type 2 diabetes on insulin therapy
    Ribeiro, Rogério Tavares, Andrade, Rita, Nascimento do Ó, Dulce, Lopes, Ana Filipa, Raposo, João Filipe · 2021 · Nutrition, Metabolism and Cardiovascular Diseases
  92. Making sense of glucose sensors in end-stage kidney disease: A review
    Mark E. Williams, Devin Steenkamp, Howard A. Wolpert · 2022 · Frontiers in Clinical Diabetes and Healthcare
  93. Machine Learning–Based Time in Patterns for Blood Glucose Fluctuation Pattern Recognition in Type 1 Diabetes Management: Development and Validation Study
    Nicholas Berin Chan, Weizi Li, Theingi Aung, Eghosa Bazuaye, Rosa Montero · 2023 · JMIR AI
  94. To What Extent Is HbA1c Associated with Glycemic Variability in Patients with Type 1 Diabetes? A Retrospective, Noninterventional Study
    Sandra Lazăr, Ioana Ioniță, Delia Reurean‐Pintilei, Romulus Zorin Timar, Silvia Ana Luca, Bogdan Timar · 2024 · Journal of Clinical Medicine
  95. Continuous Glucose Monitoring Metrics and Hemoglobin A1c Relationship in Patients with Type 2 Diabetes Treated by Hemodialysis
    Rodolfo Javier Galindo, Bobak Moazzami, Katherine R. Tuttle, Richard M. Bergenstal, Limin Peng, Guillermo E. Umpierrez · 2024 · Diabetes Technology & Therapeutics
  96. Glycemic Variability and Its Association with Traditional Glycemic Control Biomarkers in Patients with Type 1 Diabetes: A Cross-Sectional, Multicenter Study
    Sandra Lazăr, Delia Reurean‐Pintilei, Ioana Ioniță, Vlad Florian Avram, Andreea Herascu, Bogdan Timar · 2025 · Journal of Clinical Medicine
  97. Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C)
    Thomas W. Martens, Richard M. Bergenstal, Teresa L. Pearson, Anders L. Carlson, Gary Scheiner, Campos Carlos, Birong Liao, Kristen E. Syring, Roy Daniel Pollom · 2020 · Postgraduate Medicine
  98. Metabolic syndrome associated with higher glycemic variability in type 1 diabetes: A multicenter cross-sectional study in china
    Keyu Guo, Liyin Zhang, Jianan Ye, Xiaohong Niu, Hongwei� Jiang, Shenglian Gan, Jian Zhou, Lin Yang, Zhiguang Zhou · 2022 · Frontiers in Endocrinology
  99. Determinants of a good perinatal outcome in 588 pregnancies in women with type 1 diabetes
    Jacques A. Lepercq, Camille Le Ray, C. Godefroy, Laurence Pelage, Danièle Dubois‐Laforgue, José Timsit · 2018 · Diabetes & Metabolism
  100. Effect of mean HbA1c on the association of HbA1c variability and all‐cause mortality in patients with type 2 diabetes
    Juei‐Yu Tseng, Hsin‐Hung Chen, Kuo‐Chin Huang, Sheng-Pang Hsu, Ching‐Chu Chen · 2020 · Diabetes Obesity and Metabolism